Nasdaq Combined Compos (COMPX.US)

Close: 9 731.18 (+19.21), Feb 14, 2020
Automatic technical analysis
Medium term
Recommendation one to six months
Positive

Low risk

Liquidity risk: LowVolatility risk: Low

Indicators 

Rising trend

Trend floor at 9505.61 (-2.3%).
Trend ceiling at 9828.85 (+1.0%).
Annualized rate of increase 72%.

Negative volume balance

VolBal22: -23

Postitive momentum

RSI21: 66

Analyses


Short

Medium

Long

Overall

Automatic technical analysis. Medium term, Feb 14, 2020

Investors have paid higher prices over time to buy Nasdaq Combined Composite Index and the index is in a rising trend channel in the medium long term. Rising trends indicate that the market experiences positive development and that buy interest among investors is increasing. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the index has support at approximately 8200 points. The index is assessed as technically positive for the medium long term.

Recommendation one to six months: Positive (Score: 94)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.83%2 053.32+0.20%
5 days71.022.75%2 104.40+2.21%
22 days-23.487.32%2 182.80+5.19%
66 days3.6315.40%2 074.52+14.82%

More analyses of Nasdaq Combined Composite Index

chart Nasdaq Combined Composite Index (COMPX) Candlesticks 22 Days
Candlesticks
chart Nasdaq Combined Composite Index (COMPX) Short term
Short term: Positive
chart Nasdaq Combined Composite Index (COMPX) Medium term
Medium term: Positive
chart Nasdaq Combined Composite Index (COMPX) Long term
Long term: Positive




 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now